-
From Data to Actionable Insight: A Collaborative Monitoring & Evaluation (M&E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception
Mar 10, 2025, 14:00 PM -
Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel
Mar 10, 2025, 14:00 PM -
Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity
Mar 10, 2025, 14:00 PM -
Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure
Mar 10, 2025, 14:00 PM -
DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
Mar 10, 2025, 14:00 PM -
Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024
Mar 10, 2025, 14:00 PM -
Differential Item Functioning With the National Eye Institute Visual Function Questionnaire-25 in Patients With Vitreomacular Traction
Mar 10, 2025, 14:00 PM -
Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality Of Life And Asthma Control In Patients With And Without Coexisting Type 2 Conditions: Results From The RAPID Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Intensity-Modulated Proton Therapy (IMPT) for the Treatment of Head and Neck Oropharyngeal Carcinoma
Mar 10, 2025, 14:00 PM -
All for One and One for All? Patterns of Familial Influenza Vaccination
Mar 10, 2025, 14:00 PM -
Cost Opportunity of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments - Brazilian Cost Analysis
Mar 10, 2025, 14:00 PM -
Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Health and Economic Value of Pneumococcal Conjugate Vaccine Against Antimicrobial Resistance in Brazil: An Agent-based Simulation Study
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance
Mar 10, 2025, 14:00 PM -
Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival
Mar 10, 2025, 14:00 PM